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INTRODUCTION
Age-related macular degeneration (AMD) causes 5% of global 
blindness and 1% of visual impairment(1,2). In the early stages of AMD, 
deposits of drusen are observed in the retina between the retinal 
pigment epithelium and choroid in the macular region(3). The disease 
progresses to more advanced stages, leading to 2 types of late AMD: 
geographic atrophy of the retinal pigment epithelium and photo-
receptor cells (dry AMD) and aberrant choroidal neovascularization 
(wet AMD), which leads to central vision loss(3).
AMD is the leading cause of blindness among the elderly in de-
veloped countries with prevalence of late AMD at 1.2-1.7%(4-9). While 
AMD has generally been a greater issue in developed countries, stu-
dies from India suggest similar prevalence (1.4-1.8%) for late AMD as 
the population continues to age in developing countries(10,11). China, 
on the other hand, has a considerably lower prevalence as confirmed 
by the Beijing Eye Study(12).
AMD was considered untreatable until argon laser treatment and, 
later, photodynamic therapy were applied(13). Today, intravitreal an-
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ABSTRACT 
Purposes: To assess the risk factors of age-related macular degeneration in Ar -
gentina using a case-control study. 
Methods: Surveys were used for subjects’ antioxidant intake, age/gender, race, 
body mass index, hypertension, diabetes (and type of treatment), smoking, sun-
light exposure, red meat consumption, fish consumption, presence of age-related 
macular degeneration and family history of age-related macular degeneration. 
Main effects models for logistic regression and ordinal logistic regression were 
used to analyze the results. 
Results: There were 175 cases and 175 controls with a mean age of 75.4 years 
and 75.5 years, respectively, of whom 236 (67.4%) were female. Of the cases with 
age-related macular degeneration, 159 (45.4%) had age-related macular dege-
neration in their left eyes, 154 (44.0%) in their right eyes, and 138 (39.4%) in both 
eyes. Of the cases with age-related macular degeneration in their left eyes, 47.8% 
had the dry type, 40.3% had the wet type, and the type was unknown for 11.9%. 
The comparable figures for right eyes were: 51.9%, 34.4%, and 13.7%, respectively. 
The main effects model was dominated by higher sunlight exposure (OR [odds 
ratio]: 3.3) and a family history of age-related macular degeneration (OR: 4.3). 
Other factors included hypertension (OR: 2.1), smoking (OR: 2.2), and being of the 
Mestizo race, which lowered the risk of age-related macular degeneration (OR: 
0.40). Red meat/fish consumption, body mass index, and iris color did not have 
an effect. Higher age was associated with progression to more severe age-related 
macular degeneration. 
Conclusion: Sunlight exposure, family history of age-related macular degenera tion, 
and an older age were the significant risk factors. There may be other variables, as 
the risk was not explained very well by the existing factors. A larger sample may 
produce different and better results.
Keywords: Age-related macular degeneration; Risk factors; Sunlight exposure; 
Fa mily history; Argentina; Case-control study 
RESUMO
Objetivo: Determinar os fatores de risco para degeneração macular relacionada à 
idade na Argentina utilizando um estudo caso-controle. 
Métodos: Questionários foram usados para a obtenção de informações dos partici-
pantes em relação à ingesta de antioxidantes, idade/sexo, raça, índice de massa cor-
poral, hipertensão, diabetes (e tipo de tratamento), tabagismo, exposição à luz solar, 
consumo de carne vermelha/peixe, presença de degeneração macular relacionada à 
idade e história familiar de degeneração macular relacionada à idade. Modelos de 
efeito principal para regressão logística e regressão logística ordinal foram usados 
para analisar os resultados. 
Resultados: Foram recrutados 175 casos e 175 controles com uma média de idade de 
75,4 anos e 75,5, respectivamente, dos quais 236 (67,4%) eram mulheres. Cento e 
cinquenta e nove (45,4%) tinham degeneração macular relacionada à idade em seus 
olhos esquerdos, 154 (44,0%) em seus olhos direitos, e 138 (39,4%) em ambos os olhos. 
Entre os casos de degeneração macular relacionada à idade no olho esquerdo, 47,8% 
apresentavam o tipo seca, 40,3% o tipo úmida, e o tipo era desconhecido em 11,9%. 
Os achados para os olhos direitos foram: 51,9%, 34,4% e 13,7%, respectivamente. O 
modelo de efeito principal foi dominado por maior exposição à luz solar (OR [odds 
ratio]: 3,3) e história familiar de degeneração macular relacionada à idade (OR: 4,3). 
Outros fatores incluindo hipertensão (OR: 2,1), tabagismo (OR: 2,2), e pertencente à 
raça mestiça, que diminuiram o risco de degeneração macular relacionada à idade 
(OR: 0,40). Consumo de carne vermelha e de peixe, índice de massa corporal e coloração 
da íris não foram fatores de risco. Idade avançada foi associada com progressão para 
degeneração macular relacionada à idade mais grave. 
Conclusão: Exposição à luz solar, história familiar de degeneração macular relaciona -
da à idade, e idade avançada foram os fatores de risco significativos. Podem existir 
outras variáveis, já que os riscos não foram bem explicados pelos fatores existentes. 
Um maior tamanho amostral poderia produzir resultados diferentes e melhores.
Descritores: Degeneração macular relacionada à idade; Fatores de risco; Exposição 
solar; História familiar; Argentina; Estudo caso-controle
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ti-vascular endothelial growth factor (VEGF) therapy is the preferred 
treatment, which has decreased the annual incidence of visual im-
pairment due to AMD by 32-50% in some developed countries(13-16). 
Anti-VEGF therapy is effective, although it does not restore vision 
to previous levels in the majority of subjects treated, and it requires 
multiple injections that are very costly(17). 
Over the past 2 decades, efforts have been made to identify as -
sociations between AMD and risk factors with varied results, but it 
is generally agreed that older age, female gender, Caucasian race, 
and family history of AMD are significant unmodifiable risk factors to 
developing the disease and/or progressing to late AMD and smoking 
might be a modifiable risk factor. An algorithm was developed to 
predict which subjects with early/intermediate AMD are most likely 
to progress to late dry/wet AMD, by assessing the following varia-
bles: 6 genetic variants, age, sex, education, baseline AMD grade, 
smoking, Body Mass Index (BMI), and nutritional supplement use(18). 
Multivariate risk models were next modified to additionally include 
time varying rates of progression of up to 12 years and macular dru-
sen size in both eyes at baseline to follow the disease progression 
in the Age-Related Eye Disease Study(19). Of the 2,937 subjects who 
participated in study, 819 progressed to late AMD during the 12-year 
follow-up period. Age, smoking, BMI, genetic variants, advanced AMD 
in one eye and drusen size in both were independently associated 
with progression(19).
In Latin America, AMD treatment is very costly, and little research 
has been done on the disease(20). Approximately 8.3% of the popu-
lation of Latin America and the Caribbean is 65 years or older(21). 
Argentina has one of the highest elderly populations in the region 
with up to 13.1% being 65 years or older, and 97% of the population 
of Argentina is White (mainly of Spanish and Italian descent) and 
3% is Mestizo (of mixed White and Indigenous race), Indigenous, or 
of another race(21,22). Despite its significantly aging population, there 
have been no studies to date on AMD in Argentina, where epide-
miological studies on blindness suggest that AMD may be the cause 
of 3-4% of blindness(20). The objective of this case-control study is to 
assess the risk factors for the development and progression of AMD 
in Argentina.
METHODS
The study adhered to the tenets of the Declaration of Helsinki, 
and the IRB of the Fundación Hugo D. Nano in Buenos Aires, Argenti-
na determined that it was exempt from formal IRB review.
Fundación Nano in Buenos Aires, Argentina contacted ophthal-
mologists throughout the country to participate in the study, and 28 
participated, including 12 retina specialists and 2 general ophthal-
mologists. The ophthalmologists considered all new patients seen 
over a 2-month period in 2011 at their respective outpatient clinics 
for the survey on the possible risk factors of AMD provided that 
they did not have maculopathy. After patients voluntarily consen-
ted, surveys were conducted by their respective ophthalmologists 
during their consultations. The participating ophthalmologists and 
their subjects were from Buenos Aires City (the Federal Capital) and 
5 interior provinces: Gran Buenos Aires, Santa Cruz, Santa Fe, Entre 
Rios, and Cordoba.
In the survey, subjects answered questions, when applicable, on 
their age, gender, race, iris color, systemic hypertension (defined as 
systolic blood pressure ≥130), diabetes (Type I or Type II and type of 
treatment), cholesterol, status of AMD in each eye, family history of 
AMD, smoking and exposure to smoking, red meat consumption, fish 
consumption, and antioxidants intake. Weight, height, and abdomi-
nal diameter were measured at the time of the survey to calculate 
BMI, and the status of AMD in each eye was also measured during the 
same consultation.
The treating ophthalmologists submitted the subjects to oph -
thal mological examination, classified AMD in each eye based on the 
standard classification of the disease, and also performed an Amsler 
grid test on each eye. Early AMD was classified as a presence of a few 
medium-sized drusen and/or pigment abnormalities(23). Intermediate 
AMD was classified as a presence of at least one large drusen, nume-
rous medium-sized drusen, and/or geographic atrophy that did not ex-
tend to the center of the macula. Advanced non-neovascular AMD was 
classified as presence of drusen and geographic atrophy extending to 
the center of the macula. Advanced neo-vascular AMD was classified 
as presence of choroidal neovascularization and any of its potential se-
quelae, including subretinal fluid, lipid deposition, hemorrhage, retinal 
pigment epithelium detachment, and a fibrotic scar(23). Subjects with 
no history or signs of AMD were selected as controls.
Risk analysis was performed with a main effects model for logis -
tic regression and ordinal logistic regression. Antioxidant status 
(taking antioxidants or not) was omitted from the potential list of 
variables because about 15% of data were missing for the cases 
and controls. Age and gender were checked but not included in any 
simple logistic regression models as they are controlled for in the 
case matching. Race was categorized as White, Mestizo, and other 
(Indigenous, Black, or Asian), with White as reference. BMI was cal -
culated by dividing weight in kilograms by the square of height 
in meters and categorized as being normal/slightly underweight 
(>18.5 kg/m2 and <25 kg/m2), overweight (25-29.9 kg/m2), and 
obese or morbidly obese (≥30 kg/m2)(24). Systemic hypertension was 
categorized as present or not, with no hypertension as reference. 
Diabetes was categorized as present (Type I or Type II) or not, with no 
diabetes as reference. Diabetes treatment was categorized as none, 
diet, oral drugs, and insulin, but treatment was only used if diabetes 
was a significant factor. Smoking was categorized as current smoker 
or not; packs per day (0, <1, 1-2, or >2); smoking years (0 years; <10 
years; 10-20 years, and >20 years); and years of giving up smoking 
(0 years, <10 years, 10-20 years, >20 years, and never smoked). Lives 
with smoker and lived with smoker were employed as dichotomous 
variables (present or not). Sunlight exposure was classified as an 
ordinal 2-level factor (light to moderate: 0-2 hours per day of sun-
light exposure and moderate to heavy: +6 hours per day). Red meat 
consumption was classified as an ordinal 4-level factor (never, once a 
week, twice a week, and 3 or more times a week). Fish consumption 
was also classified as an ordinal 4-level factor (never, once a month, 
once a week, and 3 or more times a week). Iris color was categorized 
as brown, light to blue, and intermediate, with brown as reference. 
AMD was categorized as present or not for each eye. For the logistic 
regression, AMD was classified as present for the cases only and not 
for the controls. AMD type was categorized as none, dry, wet, or 
unknown, but was only used in the ordinal logistic regression. Fundus 
status for either eye was not used in the logistic regression.
In the logistic regression main effects model, all variables were 
initially entered into a single block, and those with a p value >0.15 
were removed. Non-significant variables (p>0.05) were then remo-
ved singly with each remaining significant variable in a single block. 
Variables with a p value less than 0.05 were significant. Retention 
of variables in the model was determined by Wald significance and 
block significance (chi square). Non-linearity of retained variables was 
not examined; for a small dataset these would need to be modeled 
in a mixed model although some idea of non-linearity could be ob-
tained from the adjusted odds ratios (ORs).
In the ordinal logistic regression main effects model, the most 
severe AMD indication in either eye was taken as the score (1-4) for 
the dependent variable. All variables were entered into a single block 
and those with a p value >0.05 removed. The variables age and BMI 
categories were retained.
RESULTS
There were 175 cases and 175 controls, of whom 236 (67.4%) were 
female. The mean ages of the cases and controls were 75.4 years (SD: 
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7.75) and 75.5 years (SD: 7.87), respectively, showing that the cases 
were well matched to controls age-wise.
Of the cases, 154 (88.0%) had AMD in their right eyes, 159 (90.9%) 
had AMD in their left eyes, and 138 (78.9%) had AMD in both eyes. 
Of the cases with AMD in their right eyes, 80 (51.9%) had the dry 
type, 53 (34.4%) had the wet type, and in 21 (13.7%), the type was 
unknown. The comparable figures for left eyes were: 76 (47.8%), 64 
(40.3%), and 19 (11.9%), respectively. The severity of AMD in each eye 
is shown in tables 1A and 1B based on the complete data for each 
eye available at the time of analysis.
With regard to demographics of all subjects, 284 were White 
(81.1%), 52 Mestizo (14.9%), and 14 of other races (4.0%). Fifty-eight 
percent reported on the surveys that they had systemic hyperten-
sion (n=203), and 49 reported to have diabetes (14.0%), of whom 7 
controlled their diabetes through diet (2.0%), 38 through oral drugs 
(10.9%), and 4 with insulin (1.1%). Almost one-third of subjects had 
a BMI that indicated they were slightly underweight or of normal 
weight (n=116, 33.1%), 142 (40.6%) were overweight, and 92 (26.3%) 
were obese or morbidly obese. Fifty-four subjects (15.4%) said they 
currently smoked, 40 subjects (11.4%) said they currently lived with 
a smoker, and 105 subjects (30.0%) said they previously lived with a 
smoker. Two-hundred-and-nine subjects (59.7%) said they had never 
smoked, while 141 subjects had smoked at some point in their life, of 
which 53 (15.1%) had given up for more than 20 years. Other data on 
smoking were too inconsistent to provide reliable results.
The majority had brown irises (222, 63.4%), while 80 (22.9%) had 
light-to-blue color, and 48 (13.7%) had intermediate color irises. 
Fifty-two subjects (14.9%) said they had a family history of AMD. 
The numbers were the same for those that had no family history or 
did not know (n=149 each; 42.6% each).
The majority of subjects received moderate-to-heavy sunlight 
exposure (n=247, 70.6%), while only 103 (29.4%) of subjects had li-
ght-to-moderate sunlight exposure. Fish and red meat consumption 
are shown in table 2.
The final main effects model in the logistic regression (Table 3) 
had a Nagelkerke R2 of 0.267, a Hosmer and Lemeshow test value of 
0.578, and an overall percentage of correct classifications of 68.9% 
(cut point 0.5).
Interpretation of the main effects model shows that it is domina-
ted by higher sunlight exposure (OR: 3.3) and a family history of AMD 
(OR: 4.3) (Table 3). The unknown category for AMD family history was 
also very significant because it most likely contains many subjects 
who have a family history of AMD. Other factors include systemic 
hypertension (OR: 2.1) and smoking (OR: 2.2). Finally, being of the 
Mestizo race lowers the risk of getting AMD (OR: 0.40).
For the ordinal logistic regression, the final main effects model 
had a Nagelkerke R2 of 0.263, a model fitting p value of 1.9 x 10-7, 
with significant parameters listed in table 4. In this ordinal logistic 
Table 1. A) Severity of age-related macular degeneration in each eye 
for logistic regression analysis*
AMD severity
Right eye 
n (%)
Left eye 
n (%)
Early 43 (26.9) 40 (24.5)
Severe 31 (19.4) 25 (15.3)
Advanced non-neovascular 32 (20.0) 43 (26.4)
Advanced neovascular 54 (33.7) 55 (33.8)
*= the table above shows severity for the eyes with complete data at the time of the 
logistic regression analysis. Three eyes did not have complete data and were not 
included. AMD= age-related macular degeneration.
Table 1. B) Severity of age-related macular degeneration in each eye 
for ordinal logistic regression analysis*
AMD severity
Right eye 
n (%)
Left eye 
n (%)
Early 43 (26.9) 38 (23.8)
Severe 31 (19.4) 25 (15.6)
Advanced non-neovascular 32 (20.0) 41 (25.6)
Advanced neovascular 54 (33.7) 47 (29.4)
*= the table above shows severity for the eyes with complete data at the time of the 
ordinal logistic regression analysis. AMD= age-related macular degeneration.
Table 2. Fish and meat consumption
Consumption rate
Meat 
n (%)
Fish 
n (%)
Never 026 (7.4) 094 (26.9)
Once a month — 060 (17.1)
Once a week 080 (22.9) 134 (38.3)
Twice a week 137 (39.1) —
Three or more times a week 107 (30.6) 062 (17.7)
Table 4. Main effects model, ordinal logistic regression
Parameter B coefficient* P† OR‡ 95% CI§
BMI category||
Obese -1.041 0.007 2.830 1.330-6.060
Overweight -0.280 0.478 1.320 0.610-2.860
Age category (years) ¶
>84 -3.859 5.6 x 10-6 0.021 0.004-0.110
80-84 -2.697 0.000045 0.067 0.018-0.250
75-79 -2.020 0.001 0.133 0.039-0.450
70-74 -1.593 0.012 0.203 0.059-0.700
65-69 -1.042 0.117 0.353 0.096-1.300
*= coefficients for the predictor variables; †P (value)= significance; ‡OR= odds ratio; §CI= 
confidence intervals; ||BMI= body mass index reference is normal or slightly underweight 
(18.5 kg/m2 and <25 kg/m2); ¶= reference is <65 years. 
Table 3. Main effects model, logistic regression
Parameter B* SE† P‡ OR§ 95% CI||
Race 0.016
Mestizo -0.924 0.363 0.011 0.397 0.20-0.81
Other -0.931 0.618 0.132 0.394 0.12-1.32
Hypertension -0.752 0.247 0.002 2.122 1.31-3.44
Smoker -0.782 0.357 0.028 2.187 1.09-4.40
Moderate-to-heavy 
sunlight exposure
-1.188 0.275 1.5 x 10-5 3.281 1.91-5.62
AMD familial history 7.8 x 10-6
Yes -1.465 0.371 7.9 x 10-5 4.329 2.09-8.96
Unknown -1.067 0.263 5.1 x 10-5 2.907 1.74-4.87
*B= logistic coefficients; †SE= standard error; ‡P (value)= significance; §OR= odds ratio; ||CI= 
confidence intervals. The reference for race is White, for hypertension no hypertension, 
for smoking status no smoking, for sunlight exposure light-to-moderate exposure (0-6 
hours of sunlight exposure per day), and for age-related macular degeneration (AMD) 
familial history no history of AMD.
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regression, an OR >1 means an association with a lower score or less 
AMD severity, while an OR <1 indicates an association with higher 
scores or higher AMD severity.
As expected, age shows a steady dose-response relationship with 
higher age associated with progression to more severe AMD. Higher 
BMI, however, appears somewhat protective in AMD progression 
(only obese BMI is significant), which might indicate selection bias, 
but the explanation for this is unknown.
DISCUSSION
Increased sunlight exposure and a family history of AMD were the 
most significant risk factors in developing AMD that were observed in 
this study in addition to hypertension, smoking, and being white. An 
older age was a significant risk for disease progression.
Sunlight exposure has produced inconsistent results as a risk 
factor in other research. A study carried out in the South of France, 
which used ambient solar radiation to test for an association of more 
sunlight exposure with AMD, did not conclude that there was an 
effect; however, a Canadian study considered sunlight exposure to 
be a possible risk factor(5,25).
For family history, the results of the unknown variable (OR: 2.9) 
are also significant and suggest that many of these subjects may 
indeed have a family history of AMD. It is, therefore, very important 
that greater attention in Argentina be given to raising awareness of 
AMD and its risks not only with subjects, but with their families, who 
should be informed of the association between family history and 
AMD. These results and recommendations were also confirmed by 
another case-control study in the UK, which found that family history 
was associated with a 12-fold increase in the odds for disease(3).
Being of the Mestizo race reduces the risk of developing AMD 
(OR: 0.40). Other Hispanic populations have also been found to have 
a reduced risk of developing late AMD(9). The US National Health and 
Nutrition Examination Survey III was a national representative po-
pulation-based, cross-sectional study that looked at the prevalence 
and risk factors for AMD in non-Hispanic whites, non-Hispanic blacks, 
and Mexican Americans. The rates were overall not very different, but 
late AMD was higher among whites. White and black women were 
more likely to develop it then their male counterparts. However, 
Mexican-American women did not have an increased risk(9). That 
said, the proportion of the Mexican population that is Mestizo is 60%, 
and only 9% is white, whereas 97% of the population of Argentina 
is White and only 3% is Mestizo, Indigenous, or of another race(22). (It 
should be further noted that the majority of subjects in this study 
were white (81%), which is a close representative proportion of the 
demographics of the country). Therefore, from a national, demogra-
phic perspective, almost the entire population of Argentina has an 
increased risk of developing AMD.
It is interesting to note that red meat consumption, fish con-
sumption, BMI, and iris color did not result in an association with 
AMD. The previously mentioned Canadian study determined that 
family history, obesity, and smoking were significant risk factors, and 
a lighter colored iris (and sun exposure) was a possible factor(5). Fish 
consumption as a risk factor has also produced mixed results in other 
studies. Studies in the United States (US) and Australia found that fish 
consumption reduces the risk of developing AMD, whereas another 
cohort in Australia did not find any significant association(26-29).
An older age was the significant risk factor for progression to 
more severe AMD. It was not clear, however, why a higher BMI, with 
the exception of the obese category, seemed to reduce the risk. Ano-
ther study found that a greater BMI, waste circumference, and waist to 
hip ratio increased the risk for progression to late AMD(30).
This case-control study was the first investigation of AMD in Ar-
gentina, and the results of the study mirror to an extent the risks fac-
tors concluded in other work. There were, however, some limitations 
that may have impacted the results. Subjects were not randomly 
selected for participation. The methodology for obtaining the data 
relied heavily on follow-up personal communications between the 
researchers and the participating ophthalmologists. Unfortunately, 
incomplete data were not uncommon. Undiagnosed diabetes and 
systemic hypertension might bias their respective association with 
AMD. It should also be noted that the classification response (not 
shown) was not that good, so there may be other variables that are 
needed in the risk analysis model. The sample size was also small; a 
larger sample size with more participating regional eye care programs 
would perhaps provide a broader perspective to the risk factors of 
AMD in Argentina, more data, and different significant variables. In 
the ordinal logistic regression, a test for parallel lines could not be run 
because convergence could not be attained or ascertained in estima-
ting the general model. The levels of the variables were still plotted 
(not shown), and in both instances were distinctly non-parallel, which 
is a limitation of this model. The existing factors seemingly do not 
explain very well the risk of developing AMD, but these factors also 
produced inconsistencies among previous studies.
Sunlight exposure, family history of AMD, and being older were 
the significant risk factors for the development and progression of 
AMD revealed in this case-control study in Argentina. There may be 
other variables, as the risk was not explained very well by the existing 
factors. However, apart from age and family history, the literature 
search generally demonstrated conflicting results from one study 
to the next, which may suggest that risk factors are specific to each 
population in each of their environments, based on the variable 
exposures. A future study in Argentina that uses a larger sample may 
produce different, stronger, and/or better results.
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